Previous Close | 20.52 |
Open | 28.98 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 26.86 - 28.98 |
52 Week Range | 17.78 - 28.98 |
Volume | |
Avg. Volume | 7,029 |
Market Cap | 24.586B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 12, 2022 |
1y Target Est | N/A |
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US (provision recognized of EUR 982 million)Income from operations EUR -824 million, including above provisionAdjusted EBITA margin of 9.4% of salesFree cash outflow of EUR 336 millionEUR 540 million agreement reached with insurers for Respironics recall-related produ
April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA and Philips Respironics have now reached final agreement on the consent decree with the DOJ and FDA. As previously stated: The consent decree primarily focuses on Philips Respironics’ business operations in the US.It provides clarity and a roadmap to demonstrate compliance with regulatory requirements and to restore
Mom & Baby Mobile Health Center® April 4, 2024 Mom & Baby Mobile Health Centers offering ultrasound screenings to expectant moms in Phoenix, Tucson, and Washington, DC Amsterdam, the Netherlands, and Arlington, VA – Philips Foundation, with its mission to provide access to quality healthcare for 100 million people a year in underserved communities by 2030, is facilitating access to prenatal care through March of Dimes Mom & Baby Mobile Health Centers® in Phoenix, Tucson and Washington, DC. Throu